Skip to content
Biodatica
Start free

ONTARIO INSTITUTE FOR CANCER RESEARCH

TORONTO, ON

OncologyGrant-only
Compare Sign in to watch

What changed

NIH U01 · $0.6M · Pangenome-Aware Methods for Accurate Somatic Variant Discovery in Cancer Genomics

2mo agoNew grantApr 27, 2026Source filing (opens the source filing in a new tab)

Momentum

67no change

Momentum 67 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

13,204 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    U01 · $594k · non-dilutive

    May 1, 2026

    UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI PATEN, BENEDICT · NCI · award ends Apr 30, 2029 · Pangenome-Aware Methods for Accurate Somatic Variant Discovery in Cancer Genomics

    NIH RePORTER · NIH RePORTER 11294518 (opens the source filing in a new tab)

  2. Grant

    R01 · $633k · non-dilutive

    Sep 26, 2025

    UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI PATEN, BENEDICT · NHGRI · award ends Jun 30, 2029 · New methods for studying thousands of complete human and vertebrate genomes

    NIH RePORTER · NIH RePORTER 11206744 (opens the source filing in a new tab)

  3. Grant

    U24 · $280k · non-dilutive

    Aug 18, 2022

    ONTARIO INSTITUTE FOR CANCER RESEARCH · PI STEIN, LINCOLN D. · NHGRI · award ends May 31, 2027 · Reactome: An Open Knowledgebase of Human Pathways.

    NIH RePORTER · NIH RePORTER 11419985 (opens the source filing in a new tab)

  4. Grant

    U24 · $332k · non-dilutive

    Aug 18, 2022

    ONTARIO INSTITUTE FOR CANCER RESEARCH · PI STEIN, LINCOLN D. · NHGRI · award ends May 31, 2027 · Reactome: An Open Knowledgebase of Human Pathways.

    NIH RePORTER · NIH RePORTER 11419984 (opens the source filing in a new tab)

  5. Grant

    U24 · $661k · non-dilutive

    Aug 18, 2022

    ONTARIO INSTITUTE FOR CANCER RESEARCH · PI STEIN, LINCOLN D. · NHGRI · award ends May 31, 2027 · Reactome: An Open Knowledgebase of Human Pathways.

    NIH RePORTER · NIH RePORTER 11182532 (opens the source filing in a new tab)

  6. Grant

    U24 · $198k · non-dilutive

    Sep 20, 2021

    UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI PATEN, BENEDICT · NHGRI · award ends Jun 30, 2026 · Dockstore: The Community Platform for Reproducible Biomedical Workflows and Applications

    NIH RePORTER · NIH RePORTER 11419100 (opens the source filing in a new tab)

  7. Grant

    U24 · $692k · non-dilutive

    Sep 20, 2021

    UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI PATEN, BENEDICT · NHGRI · award ends Jun 30, 2026 · Dockstore: The Community Platform for Reproducible Biomedical Workflows and Applications

    NIH RePORTER · NIH RePORTER 11169714 (opens the source filing in a new tab)

  8. Grant

    U24 · $537k · non-dilutive

    Sep 9, 2021

    ONTARIO INSTITUTE FOR CANCER RESEARCH · PI YUNG, CHRISTINA · NCI · award ends Aug 31, 2027 · Overture: A Multi-Scale Data Platform for Cancer Genomics Research

    NIH RePORTER · NIH RePORTER 11163216 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources